Oak Associates’s AbbVie ABBV Stock Holding History

Oak Associates’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,823	Closed	-$2M	–	134
2023 Q2	$2M	Hold	14,823	–	–	0.16%	77
2023 Q1	$2.36M	Hold	14,823	–	–	0.19%	73
2022 Q4	$2.4M	Buy	14,823 +11,858	+400%	+$1.82M	0.2%	76
2022 Q3	$398K	Hold	2,965	–	–	0.03%	121
2022 Q2	$454K	Sell	2,965 -10	-0.3%	-$1.53K	0.04%	115
2022 Q1	$482K	Hold	2,975	–	–	0.03%	122
2021 Q4	$403K	Hold	2,975	–	–	0.02%	132
2021 Q3	$321K	Hold	2,975	–	–	0.02%	131
2021 Q2	$335K	Hold	2,975	–	–	0.02%	131
2021 Q1	$322K	Buy	2,975 +10	+0.3%	+$1.07K	0.02%	132
2020 Q4	$318K	Sell	2,965 -15,829	-84%	-$1.52M	0.02%	134
2020 Q3	$1.65M	Hold	18,794	–	–	0.11%	79
2020 Q2	$1.84M	Buy	+18,794	New	+$1.65M	0.12%	73
2020 Q1	–	Sell	-10,690	Closed	-$946K	–	131
2019 Q4	$946K	Sell	10,690 -3,780	-26%	-$314K	0.06%	106
2019 Q3	$1.1M	Hold	14,470	–	–	0.07%	103
2019 Q2	$1.05M	Buy	14,470 +8,020	+124%	+$630K	0.07%	103
2019 Q1	$520K	Hold	6,450	–	–	0.03%	127
2018 Q4	$595K	Hold	6,450	–	–	0.04%	111
2018 Q3	$610K	Buy	6,450 +470	+8%	+$44.6K	0.04%	129
2018 Q2	$554K	Buy	5,980 +1,040	+21%	+$102K	0.04%	127
2018 Q1	$468K	Hold	4,940	–	–	0.03%	131
2017 Q4	$478K	Hold	4,940	–	–	0.03%	134
2017 Q3	$439K	Hold	4,940	–	–	0.03%	139
2017 Q2	$358K	Buy	+4,940	New	+$332K	0.03%	152

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Associates's ABBV Position: Q3 2023 in Review

Oak Associates sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 14,823 shares — an estimated $2M sold.

Oak Associates first reported a position in ABBV in Q2 2017 and held it in 24 quarters. The position peaked at $2.4M in Q4 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Oak Associates reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
Oak Associates sold 14,823 AbbVie shares in Q3 2023, an estimated $2M.
Oak Associates first reported a position in AbbVie in Q2 2017 and held it in 24 quarters.
Oak Associates's AbbVie position peaked at $2.4M in Q4 2022.
3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Oak Associates's 13F filing for Q3 2023, filed 13 Nov 2023.